The post examines major updates in Indian patent statistics, high-profile infringement cases, and the WIPO-INDIA Summer School. It features objective insights and practical tips for IP professionals, curated by BananaIP Counsels’ expert attorneys.
Read more about WIPO Summer School, Bumble versus Tinder, Huawei versus Samsung, Qualcomm versus Apple, Patent Tip and other newsTag: patent office india
Patent opposition system in India: Pre-grant & Post grant oppositions
The Indian patent opposition system offers structured processes for pre-grant and post grant challenges to patent validity. This post outlines the procedures, grounds, and key advantages of opposition proceedings under Indian patent law.
Read more about Patent opposition system in India: Pre-grant & Post grant oppositionsIndian Patent Highlights, 2016 – Patent Office, Patent Procedure and Patent Rules
2016 marked a period of significant change for Indian patent law, with major procedural reforms and policy updates. Key highlights include the Patent (Amendment) Rules, new examination procedures, and increased support for start-ups, signalling a shift in the Indian intellectual property landscape.
Read more about Indian Patent Highlights, 2016 – Patent Office, Patent Procedure and Patent RulesPatent Amendment Rules 2016 – Courting Controversy and Confusion
The Patent Amendment Rules 2016 sparked both appreciation and confusion among stakeholders in Indian patent law. This post analyses the controversies and practical challenges arising from the new rules, urging applicants to proceed with care.
Read more about Patent Amendment Rules 2016 – Courting Controversy and ConfusionPatent Amendment Rules 2016
The Patent Amendment Rules 2016 introduce substantial updates to Indian patent law, including expedited examination and digital filing. The rules aim to enhance efficiency, support startups, and align with the National IPR Policy.
Read more about Patent Amendment Rules 2016Compulsory Licensing in India
This article analyses the evolution and practice of compulsory licensing in India, focusing on landmark cases and their effects on patent activity. It assesses whether compulsory licensing influences innovation and discusses the operational challenges within the Indian Patent Office.
Read more about Compulsory Licensing in IndiaPfizer falls prey to Section 3(d)
This post analyses the Indian Patent Office’s rejection of Pfizer’s Tofacitinib patent under Section 3(d). The decision addresses issues of novelty, inventive step, and the requirement for evidence of enhanced efficacy in pharmaceutical patent applications.
Read more about Pfizer falls prey to Section 3(d)